Revenue increased 33.0%
Revenue changed +33.0% from the comparable as-filed period.
$263.6M→$350.7M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CSW financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 24.7%
Operating cash flow changed +24.7% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
$60.6M→$75.6M6 prior comparisons
Operating income increased 45.5%
Operating income changed +45.5% from the comparable as-filed period.
$54.9M→$79.9M3 prior comparisons
Gross profit increased 36.3%
Gross profit changed +36.3% from the comparable as-filed period.
$115.4M→$157.4M3 prior comparisons
Inventory increased 40.2%
Inventory changed +40.2% from the comparable as-filed period.
$217.7M→$305.2M3 prior comparisons
Capital expenditure increased 106.7%
Capital expenditure changed +106.7% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
$2.9M→$6.0M6 prior comparisons
Inventory / revenue moved 448 bp higher
Inventory / revenue changed +448 basis points from the comparable as-filed period.
82.56%→87.04%2 prior comparisons
Operating margin moved 196 bp higher
Operating margin changed +196 basis points from the comparable as-filed period.
20.81%→22.77%3 prior comparisons
Free-cash-flow proxy increased 20.6%
Free-cash-flow proxy changed +20.6% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
$57.7M→$69.6M6 prior comparisons
Selling, general & administrative increased 28.0%
Selling, general & administrative changed +28.0% from the comparable as-filed period.
$60.6M→$77.5M3 prior comparisons
Net income increased 21.6%
Net income changed +21.6% from the comparable as-filed period.
$40.9M→$49.8M2 prior comparisons
Cash & equivalents increased 25.0%
Cash & equivalents changed +25.0% from the comparable as-filed period.
$38.0M→$47.5M2 prior comparisons
Gross margin moved 109 bp higher
Gross margin changed +109 basis points from the comparable as-filed period.
43.79%→44.88%3 prior comparisons
Capex / revenue moved 61 bp higher
Capex / revenue changed +61 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.10%→1.71%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.